Park Ha Biological Technology Co., Ltd. closed IPO, raising $4.8 million, focusing on store expansion and product development.

From GlobeNewswire: 2024-12-30 17:30:00

Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) has closed its initial public offering of 1,200,000 ordinary shares at $4.00 per share, trading on Nasdaq under “PHH.” The Company raised $4.8 million before expenses and granted underwriters an option to purchase 180,000 additional shares. Proceeds will fund store expansion, product development, and ingredient supplier acquisitions. The Offering was conducted by Dawson James Securities, Inc. and D. Boral Capital LLC. A registration statement was filed with the SEC, and the final prospectus is available on their website. Investors are encouraged to review all documents before investing.

Established in 2016, Park Ha Biological Technology Co., Ltd. focuses on private skincare labels, product sales, and franchise promotions under the brand “Park Ha.” The Company has two stores and 43 franchisees in China, offering after-sales beauty services. Forward-looking statements regarding the Offering have been made, with the Company emphasizing the importance of reviewing all factors that may affect future results. For more information, interested parties can visit the Company’s website or contact the Investor Relations Department. Ascent Investor Relations LLC is also available for inquiries.



Read more at GlobeNewswire: Park Ha Biological Technology Co., Ltd. Announces Closing